← board
IVEVF
distress 2/10 · well-funded / low risk$3.590%today-38% from 52w high
Revenue
pre-revenue
Liquidity
$231M
Runway
2.2 yrs
Shares 1y
0%
Price & events
-19.1% over 6M
CatalystRating changeDilutionFinancingdashed = today
+0.0%
1D
+0.0%
1W
+0.0%
1M
-32.6%
3M
-19.1%
6M
+57.5%
1Y
-1.4%
2Y
-66.9%
5Y
-66.9%
All
Overview
- Market Cap
- $693.72M
- Enterprise Value
- $621.22M
- Volume
- 0
- 52 Week Range
- $2.28 – $5.75
- Total Shares
- 193.24M
- Float Shares
- 160.69M
- % Held by Insiders
- 12.67%
- % Held by Institutions
- 49.57%
- Beta
- 0.89
Pipeline · 0 trials · 0 upcoming
| Readout | Phase | Drug | Indication | Enroll | Status |
|---|---|---|---|---|---|
| No pipeline trials tracked. | |||||
Catalyst news & presentations · 0
- No catalyst news yet.
Approved drugs (0)
- none — clinical-stage
Capital structure — dilution & financing
🔒 Top holders — Pro
Institutional ownership + quarter-over-quarter accumulation/trimming.
Upgrade to ProWall St ratings
no consensus
- no recent rating changes
Competitors
- none identified
Recent news
- none
Not financial advice. Data: ClinicalTrials.gov, SEC EDGAR, FINRA, Nasdaq, Yahoo.